Silver oxide nanoparticles comprising rhizome extract of bergenia ciliata and a method for synthesis thereof

IN603391BActive Publication Date: 2026-09-22SHOOLINI UNIV OF BIOTECH & MANAGEMENT SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
IN202011056025
Authority / Receiving Office
IN · IN
Patent Type
Patents
Current Assignee / Owner
Filing Date
2020-12-23
Publication Date
2026-09-22
Estimated Expiration
2040-12-23

AI Technical Summary

Technical Problem

Current methods for synthesizing silver oxide nanoparticles are often costly, use hazardous chemicals, and lack eco-friendly processes, particularly for producing nanoparticles with antioxidant and anticancer properties.

Method used

The synthesis of silver oxide nanoparticles using the rhizome extract of Bergenia ciliata at room temperature, which acts as a reducing and stabilizing agent, eliminating the need for hazardous chemicals and providing a cost-effective, eco-friendly method.

Benefits of technology

The method produces nanoparticles with effective antioxidant and anticancer properties, demonstrated by strong UV-visible absorption and cytotoxicity against cancer cell lines, while being non-toxic and safe for use.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

“SILVER OXIDE NANOPARTICLES COMPRISING RHIZOME EXTRACT OF BERGENIA CILIATA AND A METHOD FOR SYNTHESIS THEREOF” The present invention relates to silver oxide nanoparticles synthesized using rhizome extract of Bergenia ciliata. Silver oxide nanoparticles useful as antioxidant and anticancer agent synthesized by using rhizome extract of Bergenia ciliata and characterized in having spherical structure with size in the range of 10 to 20 nm. The method of producing silver oxide nanoparticles is performed at room temperature. The method comprises preparing the extract of plant Bergenia ciliate and adding in 40 mL of 1 mM aqueous solution of silver nitrate, freshly prepared 10 mL (1:10) of plant extract. Both the solutions are mixed. The mixture is then stirred continuously on a magnetic stirrer. After 10 minutes, the reaction starts, and a change of color can be observed from colorless to transparent yellow at different intervals and then finally to a dark brown when incubated at room temperature for 24-48 hours in the dark. The solution is then centrifuged at 10000 rpm for 10 minutes, following which the pellet is re-dispersed in the sterile distilled water to get rid of any uncoordinated biological molecules. Silver oxide nanoparticles synthesized from Bergenia ciliata possess good antioxidant and anticancer activity.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD OF THE PRESENT INVENTIONThe present invention relates to nanoparticles and a method of producing the sameand specifically, the present invention relates to silver oxide nanoparticles, and amethod for synthesis of silver oxide nanoparticles using rhizome extract ofBergenia ciliata.BACKGROUND / PRIOR ART OF THE PRESENT INVENTIONMedicinal plants have provided a reliable source for preparation of new drugs aswell as combating diseases, from the dawn of civilization. Nanotechnology is oneof the fastest growing areas of science and technology which is used tomanufacturing new materials at the nanoscale level. The synthesis of metalnanoparticles is an active area of research in the field of nanotechnology.Nanotechnology is an application that works with material that exists in the atomicand molecular range. At this size, the physical, chemical and biological propertiesof materials are different from what they were at the larger scales. Nanoparticles,generally considered as particles with a size of up to 100 nm, exhibit completelynew or improved properties as compared to the larger particles of the bulk material.Nanoparticles of noble metals, such as gold, silver, and platinum, are widely appliedin products. Metal nanoparticles, particularly the noble metals were studied mainlydue to their strong optical absorption in the visible region caused by the collectiveexcitation of free electron gas. Such coherent electron motion results in the plasmonabsorption of the surface and decays through electron-electron collisions in theorder of a few femtoseconds non-radiatively. The resonance frequencies and thewidth of the plasmon absorption band depend upon the size of the metalnanoparticles (M.B. Mohamed et. al, Chemical Physics Letters, 317, 517-523(2000).Among noble metal nanoparticles, silver nanoparticles have a broad range ofapplications such as non-linear optics, spectrally selective solar energy absorptioncoating, biolabeling, intercalation materials for electrical batteries as opticalreceptors, catalyst for chemical reactions and antibacterial capacities. Variousmethods are discovered to synthesize noble metal nanoparticles of particular formand size based on specific requirements, since the properties of metallicnanoparticles based on size and shape are of concern for applications ranging fromcatalysts and sensing to optics, antibacterial activity and data storage (X. Li, et. al,Surfactant less synthesis and the surface-enhanced Raman spectra and catalyticactivity of differently shaped silver nanomaterials, European Journal of InorganicChemistry, 12, 1806-1812 (2010).Nanotechnology plays a tremendous role in overcoming many of the problems thatconventional methods face in the treatment, diagnosis, and detection of cancer. Theprimary feature of these nanoparticles is that their surfaces can be functionalized,exploiting reactive terminal groups, with particular proteins, peptides ormonoclonal antibodies that are capable specifically to bind at a site of action or aspecific targeted tissue, without interacting with other cells (Preethi R, Anticanceractivity of silver nanobio-conjugates synthesized from Piper betle leaves extractand its active compound eugenol. Int J Pharm Pharm Sci 2016;8(9):201-5).Therefore, the use of nanotechnology in cancer treatment offers exciting possibilityof destroying cancer cells with minimal damage to healthy tissues and organs.Nanoparticles can be used in the detection and elimination of cancer cells beforethey form tumors. Nanoparticles can also be designed to carry drugs and releasethem at the targeted site. These particles can be employed as contrast agents inmagnetic resonance imaging for diagnostic purposes and treatment monitoring. Inparticular, silver nanoparticles commands much enthusiasm among the risingnanoproducts in the field of nanomedicine because of their exceptional propertiesand clear therapeutic potential in treating a variety of diseases.Silver nanoparticles serve as antitumor agents by decreasing progressivedevelopment of tumor cells. This might be because of their inhibitory actions inseveral signaling cascades liable for the development and pathogenesis of cancer.The research studies have indicated that silver nanoparticles can actuatecytotoxicity on cancer cells and hindering tumor progression without lethality tonormal cells. Silver nanoparticles have shown anticancer activity against some ofthe human cancer cell lines such as colon carcinoma (HCT-116), breast carcinoma(MCF-7), liver carcinoma (Hep-G2), and intestinal carcinoma (Caco2) as stated byShawkey et al. A number of techniques are available for the syntheses of silvernanoparticles like ion sputtering, chemical reduction, sol gel, etc. Greener synthesesof nanoparticles also provides advancement over other methods as they are simple,one step, cost-effective, environment friendly and relatively reproducible and oftenresults in more stable materials.Many methods have been used for the synthesis of nanoparticles, like chemical andphotochemical reduction, electrochemical techniques and radiolysis methods. Thechemical or physical methods for the synthesis of silver nanoparticles suffer withvarious limitations such as expensive reagents, generation of hazardous toxicchemicals, and tedious process to isolate nanoparticles etc. Hence, there is animmediate and unmet requirement to develop new methods for the synthesis ofnanoparticles that requires inexpensive reagents, requires simple reaction conditionand are eco-friendly.In contrast, "Green synthesis" of nanoparticles makes use of environment friendly,non-toxic and safe reagents. The green synthesis of nanoparticles (NPs) gained alot of attention owing to the instinctive features such as usage of natural resources,rapidness, eco-friendliness and benignancy. These appealing features are essentialin medical applications. The other benefits of green synthesis include the welldefinedand controlled size. They are contaminants free and the process is easy toscale-up (A.K. Mittal et. al., Synthesis of metallic nanoparticles using plant extracts,Biotechnology Advances, 31, 346-356 (2013)). One of the green methods ofnanoparticles synthesis is the use of different plants and their components. Thenumerous biomolecules that are present in the plant extract such as flavonoids,terpenoids, enzymes, proteins and cofactors act as both reducing and capping agents(F. Tavakoli et. al., Green synthesis and characterization of graphene nanosheets,Materials Research Bulletin, 63, 51-57 (2015)).US20050008861A1 discloses nanoparticles comprising silver and theirnanotechnology-enabled applications are disclosed; doped metal oxides, silvercomprising complex nanoparticle compositions, silver nanoparticles, methods ofmanufacture, and methods of preparation of products from silver comprisingnanoparticles are presented; And anti-microbial formulations are discussed. Colorphotochromaticity and related applications are disclosed.US20090220600A1 relates to films comprising silver oxide nanoparticles in atitanium dioxide host matrix. The invention also relates to a process for theproduction of such films, and to their use in antimicrobial applications. Theinvention also provides a process for producing the film by depositing silver metalor silver alloy nanoparticles and a titanium dioxide film under conditions in whichthe silver is oxidised, or by treating films of titanium dioxide containing silvernanoparticles under conditions whereby silver may be oxidised, or by depositingsilver oxide nanoparticles and a titanium dioxide film.US20090068089A1 discloses a method of manufacture of silver oxide nano metalparticles of 2-10 mm size with specific phase and geometry in their exterior andinterior making them suitable for use as potent antimicrobial and styptic agents. Thesaid process for the manufacturing of silver nano particles comprises the reactionof a silver salt solution in the presence of a desegregating agent with a precipitatingagent at the room temperature and controlling the flow of the salt solution and theprecipitating agent to produce silver oxide nano particles.US20120189534A1 discloses manufacture of silver oxide nano particles isdisclosed comprising using Armine-z as desegregating agent for silver salt solutionand precipitating it with sodium hydroxide. The process for the manufacturing ofsilver oxide nano particles, which comprises: making a mixture of a silver saltsolution with a desegregating agent Armine-Z; adjusting maintaining the pH of saidmixture to between 12-14; combining said mixture with a solution of a precipitatingagent at a rate of 2-10 mL / min of each solution.Therefore, there is a growing need to develop eco-friendly process for synthesis ofnanoparticle without using toxic chemicals. It is now well-proven that the biologicalroute for synthesis of nanoparticles saves energy and creates comparatively lessamount of harmful waste. Such processes have involved plant metabolites, plantextracts and products of biological macromolecules such as nucleic acids, peptidesor proteins, carbohydrates, and lipids as well.US9428399B1 discloses the synthesis of nanoparticles of metals and metal oxidesusing plant seeds extract involves providing a solution comprising a metal ion;providing a plant seeds extract solution that comprises a reducing agent; andcombining the metal ion solution and the plant extract solution while stirring atroom temperature to produce metal nanoparticles. The plant extract is obtainedfrom Trigonella foenum-graecum seeds, and the metal ion is selected from thegroup consisting of silver (Ag), gold (Au) and zinc (Zn).However, none of the prior art documents disclose preparation silver oxidenanoparticles using rhizome extract of Bergenia ciliata at room temperature.The inventors of present application have provided an easy, low cost method forpreparation silver oxide nanoparticles using rhizome extract of Bergenia ciliata atroom temperature. Inventors of the present invention have worked to develop amethod for synthesis of silver oxide nanoparticles using rhizome extract of rhizomeextract of Bergenia ciliata wherein reaction is performed without using anyhazardous chemicals. Further, the silver oxide nanoparticles synthesized using themethod disclosed in present invention have antioxidant and anticancercharacteristics.SUMMARY OF THE PRESENT INVENTIONThe present invention provides a solution to the problems associated with synthesisof silver oxide nanoparticles that have effective potential for use in antioxidant andanticancer applications.According to one of the aspects of present invention, there is provided silver oxidenanoparticles synthesized by using rhizome extract of Bergenia ciliata and usefulas antioxidant and anticancer agent.In another embodiment, the invention provides a silver oxide nanoparticlesynthesized by using rhizome extract of Bergenia ciliata and having spherical shapeand size in the range of 10 nm to 20 nm.In another embodiment, the invention provides a silver oxide nanoparticlesynthesized by using rhizome extract of Bergenia ciliata and having an UV-visibleabsorption maximum in the range of 200 to 600 nm.According to another aspect of the present invention, there is provided a method forsynthesizing silver oxide nanoparticles using rhizome extract of Bergenia ciliata,comprising:i. preparing the rhizome extract of Bergenia ciliata;ii. drop wise adding freshly prepared rhizome extract of Bergeniaciliata to silver nitrate and mixing the solution;iii. continuously stirring the solution on a magnetic stirrer;iv. incubating the reaction mixture of step (iii) under static condition tillthe formation of dark brown color;v. cooling the solution;vi. putting the solution in a centrifuge of the solution at 10,000 rpm forseparating out impurities from the reaction mixture;vii. re-dispersing the solution in the sterile distilled water to remove anyuncoordinated biological molecules;viii. collecting the nanoparticles separated from the reaction mixture;ix. washing of nanoparticles with ethanol; andx. collecting nanoparticles and drying in a hot air oven at 60°C for 24hours.According to an embodiment of the present invention the method for preparation ofrhizome extract of Bergenia ciliata comprises the steps:i. collecting rhizomes of Bergenia ciliata plant;ii. washing and drying rhizomes of Bergenia ciliata plant;iii. making powder of dried rhizomes of Bergenia ciliata plant bymechanical means;iv. adding water in the ratio 1:10 w / v and boiling mixture for 30-40minutes at 50-60°C;v. cooling the solution at room temperature; andvi. filtering the solution of preceding step to have an extract containingbioactive compounds leached from rhizomes of Bergenia ciliataplant.According to an embodiment of the present invention, there is provided silver oxidenanoparticles, wherein said nanoparticles are used as antioxidant and anticanceragent for the preparation of anticancer medicaments.Other aspects, advantages of certain embodiments, and salient features of theinvention will become apparent to those skilled in the art from the detaileddescription, which, taken in conjunction with the annexed drawings and disclosedexemplary embodiments of the invention.BRIEF DESCRIPTION OF ACCOMPAYING DRAWINGSThe various aspects, features, and advantages of the present invention will be moreapparent from the following description taken in conjunction with theaccompanying drawings, in which:Figures 1(a), 1(b) & 1(c) shows visual observation of silver oxide nanoparticles(Ag2O NPs) synthesis wherein silver nitrate solution (AgNO3) is mixed withrhizome extracts of Bergenia ciliata to form silver oxide nanoparticles (Ag2O NPs).Figures 2(a) and 2(b) illustrate UV-Visible spectra and Fouriertransforminfrared spectroscopy (FT-IR) respectively of silver oxide nanoparticles(Ag2O NPs) synthesized with rhizome extract of Bergenia ciliata.Figures 3(a), 3(b), 3(c) & 3(d) illustrate X-Ray Diffraction (XRD) pattern, DynamicLight Scattering (DLS) pattern, representative Scanning Electron Microscopy(SEM) images, Energy Dispersive X-ray (EDX) analysis respectively of silveroxide nanoparticles (Ag2O NPs) synthesized with rhizome extract of Bergeniaciliata.Figures 4(a), 4(b) & 4(c) illustrate antioxidant activity of Bergenia ciliata extractand of silver oxide nanoparticles (Ag2O NPs) using a) 2,2-diphenyl-1-picrylhydrazyl (DPPH), scavenging activity b) 2, 2-azinobis (3-ethylbenzthiazoline)-6-sulfonic acid (ABTS) scavenging activity and c) ferricreducing antioxidant power (FRAP) free radicals scavenging activity respectively,wherein results were expressed as mean ± SEM.Figures 5(a) & 5(b) illustrate effect of silver oxide nanoparticles (Ag2O NPs)synthesized with rhizome extract of Bergenia ciliata and Bergenia ciliata extract invitro cytotoxicity against a ) Human Cervical Cancer (HeLa) cells and b) ) HumanColon Cancer (HT-29) cells respectively, wherein results were expressed as mean± SEM.Figures 6 illustrate effect of silver oxide nanoparticles (Ag2O NPs) synthesized withrhizome extract of Bergenia ciliate in vitro cytotoxicity against human cell linesFR2 cells.DETAILED DESCRIPTION OF THE PRESENT INVENTIONThe embodiments herein and the various features and advantageous details thereofare explained more fully with reference to the non-limiting embodiments that areillustrated in the accompanying drawings and detailed in the following description.Descriptions of well-known components and process techniques are omitted so asto not unnecessarily obscure the embodiments herein. The examples used hereinare intended merely to facilitate an understanding of ways in which theembodiments herein can be practiced and to further enable those skilled in the artto practice the embodiments herein. Accordingly, the examples should not beconstrued as limiting the scope of the invention described herein.In the present invention, the synthesis of silver oxide nanoparticles has been carriedout using the rhizome extract of Bergenia ciliata and antioxidant and anticanceractivity of silver oxide nanoparticles synthesized using rhizome extract of Bergeniaciliata are studied.In this present invention, the biosynthesis of silver oxide nanoparticles (Ag2O NPs)using rhizome extract of Bergenia ciliata at room temperature has been carried out.Bergenia ciliata belongs to the family of saxifragaceae and is mostly distributed inthe cold and temperate regions. It is found in Pakistan, India, Bhutan, Nepal andother countries.In the present invention, silver oxide nanoparticles were biosynthesized fromaqueous silver nitrate through a simple and eco-friendly route using Bergeniaciliata rhizome extracts, which acted as a reductant and stabilizer simultaneously.The prepared nanoparticles has been tested for its antioxidant and anticanceractivity.The primary material for synthesis for silver nanoparticles is silver precursors,silver nitrate(AgNO3), is used as reagent, rhizome extract of Bergenia ciliata andinstruments used in said synthesis are: Magentic Stirrer, Magnetic beads andCentrifuge system, Incubator.Method to synthesize silver oxide nanoparticles of present invention:i. Preparation of Bergenia ciliata rhizome aqueous extract - Rhizomes ofB. ciliata were collected from the Narkanda region (2700 m amsl) of Shimla district,Himachal Pradesh, India during spring season from April to June, 2018. Therhizomes are then washed, dried and powdered by grinding at room temperature.To the powder, water is added in the ratio 1:10 w / v (one part of powder and 10 partsof water) and boiled for 30-40 minutes at 50-60°C. Thereafter, it is cooled to roomtemperature and filtered to give B. ciliata extract. The filtrate obtained contains thebioactive components leached from rhizome. This filtrate was used as the extractfor the preparation of silver oxide nanoparticles.ii. Synthesis of Nanoparticles: 40 mL of 1 mM aqueous solution of silvernitrate is taken in an Erlenmeyer flask. Thereafter, freshly prepared 10 mL (1:10)of plant extract is added dropwise to silver nitrate. Both the solutions are mixed toinitiate the reduction of AgNO3 solution into Ag+ ions. The mixture is then stirredcontinuously for about 30 minutes on a magnetic stirrer. After 10 minutes, thereaction starts and a change of color can be observed from colorless to transparentyellow at different intervals and then finally to a dark brown when incubated atroom temperature for 24-48 hours in the dark.iii. Separation of nanoparticles and drying: Settled nanoparticles areseparated from solution by any appropriate filtration method, dried and washed withwater and further for characterization. In particular, in order to separate theimpurities from the solution, centrifugation is carried out at 10000 rpm for 10 min,following which the pellet is re-dispersed in the sterile distilled water to get rid ofany uncoordinated biological molecules. The process of centrifugation and redispersionin the sterile distilled water is repeated thrice to ensure a better separationof free entities from the Ag2O NPs. The suspended pellet is at last purified by usingethanol. The purified pellets are then kept into petri plates and left in the oven fordrying at 60 °C for 24 hours.The silver nitrate solution (AgNO3) was mixed with rhizome extracts of Bergeniaciliata shows change of brown colour from transparent solution which confirmedthe synthesis of silver nanoparticles. This change of colour was due to the excitationof surface vibration by the silver oxide nanoparticles (Ag2O NPs). Figures 1(a), 1(b)& 1(c) shows visual observation of silver oxide nanoparticles (Ag2O NPs) synthesiswherein silver nitrate solution (AgNO3) is mixed with rhizome extracts of Bergeniaciliata to form silver oxide nanoparticles (Ag2O NPs).The characterization of synthesized nanoparticles was carried out by UV- Visiblespectrophotometer and FT-IR analysis, X-Ray Diffraction (XRD) pattern, DynamicLight Scattering (DLS) pattern, Scanning Electron Microscopy (SEM) images,Energy Dispersive X-ray (EDX) analysis. The synthesized silver nanoparticlesshowed a strong antioxidant activity. Anticancer activity of synthesized silvernanoparticles was checked against HeLa and HT-29 cell lines.Characterization of Synthesized Ag2O NPsThe UV-Visible absorption spectrum of the samples ranging from 200 to 600 nmwas measured using Shimadzu UV-Vis V-530A spectrophotometer.The reaction mixture was determined by UV-vis from 0 till 60 minutes and formedsurface plasmon resonance of SNPs peak centered near 450 nm (Figure 2(a)) whichindicated the reduction of AgNO3 into Ag2O NPs. This biosynthesis of silvernanoparticles was completed with 15 minutes at room temperature after reductionof AgNO3 into Ag2O NPs.Figure 2(a) illustrates UV-Visible spectra of silver oxide nanoparticles (Ag2O NPs)synthesized with rhizome extract of Bergenia ciliata.The FTIR spectrum (Perkin-Elmer-Spectrum Two) was observed at 400-4000 cm- 1 of wavelength. FTIR analysis was carried out to observe the functional groupswhich showed by FT-IR and showed clear absorption peaks located 3287, 2919,2850, 2360, 1708, 1648, 1539, 1457, 1054, 720 and 510 cm-1. which wereassociated with O-H, N-H, S-H, C≡N, C=C=C and N=C=S stretching. There wasthe presence of alcohol, aliphatic primary amine, thiol, nitrile, alkenes andisothiocyanate respectively. From FTIR results, it was confirmed that some of thebioorganics compounds from plant extract formed a strong coating / capping on thenanoparticles.Figure 2(b) illustrates UV-Visible spectra and Fouriertransform infrared spectroscopy (FT-IR) respectively of silver oxide nanoparticles(Ag2O NPs) synthesized with rhizome extract of Bergenia ciliata.In addition, with this device, and Energy Dispersive X-ray Analysis (EDAX) andelemental mapping were performed. XRD pattern of Ag2O NPs was obtained usinga powder X-ray diffractometer (Philps X'Pert Pro X-ray diffractometer) withCu(Kα) radiations (1.5406 Å) in 2θ range from 10 °C to 80 °C was done using thesame instrument at Indian Institute of Technology, Mandi.The powder X-ray diffraction spectra of the formed Ag2O NPs were displayed in(Figure 3(a)), confirming the occurrence of genuine Ag2O NPs. The XRD spectraobtained were confirmed against the standard spectra of Ag2O (JCPDS no. 00-012-0793). At 2θ values of 38.05, 43.90 and 65.58, several Bragg reflection peaks wereobserved, which are indexed to (111), (211), and (222) planes of pure Ag2O NPs.The average crystalline size of NPs was calculated using the Debye-Scherrer'sequation as follows:D= Kλ / βcosθwhere K is Scherrer's constant (K= 0.94), D is the mean crystalline size, k is the Xraywavelength (0.1546 nm), b is the fullwidth at half-maximum of the XRD linein radians, and 'θ' is the Bragg angle. The average crystallite size calculated fromXRD spectral data using Scherrer's equation was 5 nm.Figure 3(a) illustrates X-Ray Diffraction (XRD) pattern of silver oxidenanoparticles (Ag2O NPs) synthesized with rhizome extract of Bergenia ciliata.DynaPro Plate Reader (Wyatt Technology) was used for Dynamic Light Scattering(DLS) analysis of silver oxide nanoparticles. DLS analysis showed the sizedistribution of particles with maximum intensity at 10-20 nm (Figure 3(b)).Figure 3(b) illustrates Dynamic Light Scattering (DLS) pattern of silver oxidenanoparticles (Ag2O NPs) synthesized with rhizome extract of Bergenia ciliata.The form and morphology of NPs were revealed using a Scanning ElectronMicroscopy (SEM-Hitachi / s-4200 N).The SEM images showed the presence of surface roughness and spherical structuresof Ag2ONPs (Figure 3(c)). EDS spectrum revealed distinct signals in the silverregion and confirm the formation of silver (Ag) and oxygen (O) and its elementalnature (Figure 3(d)).Figure 3(c) illustrates representative Scanning Electron Microscopy (SEM) imagesof silver oxide nanoparticles (Ag2O NPs) synthesized with rhizome extract ofBergenia ciliata.Figure 3(d) illustrates Energy Dispersive X-ray (EDX) analysis of silver oxidenanoparticles (Ag2O NPs) synthesized with rhizome extract of Bergenia ciliata.Biological activity of the Silver oxide Nanoparticles:Antioxidant assayThe antioxidant activity was analyzed using chemical based assays. 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2, 2-azinobis (3-ethylbenzthiazoline)-6-sulfonic acid(ABTS) and ferric reducing antioxidant power (FRAP) free radicals scavengingassay were used to determine the antioxidant potential of synthesized greennanoparticles using standard procedures.Antioxidant activityThe extract of B. ciliata rhizomes and Ag2O NPs exhibited potential antioxidantproperties. In case of DPPH, the best activity was observed in Ag2O NPs (IC50 =80.6 μg / mL), while Bergenia ciliata extract (IC50 = 135.2 μg / mL) respectively(Figures 4a and 4b). In case of ABTS assay the best activity was also observed inAg2O NPs (IC50 =93.8 μg / mL), followed by plant extract (IC50 = 138.0 μg / mL). Incase of FRAP assay, the best activity was also observed in Ag2O NPs (IC50 =83.3μg / mL), followed by plant extract (IC50 = 138.2 μg / mL). Ascorbic acid was usedas a standard, which exhibited an IC50 value of 29.4, 28.7and 26.3 μg / mL for DPPH,ABTS and FRAP assay, respectively.Figures 4(a), 4(b) & 4(c) illustrate antioxidant activity of Bergenia ciliata extractand of silver oxide nanoparticles (Ag2O NPs) using a) 2,2-diphenyl-1-picrylhydrazyl (DPPH), scavenging activity b) 2, 2-azinobis (3-ethylbenzthiazoline)-6-sulfonic acid (ABTS) scavenging activity and c) ferricreducing antioxidant power (FRAP) free radicals scavenging activity respectively,wherein results were expressed as mean ± SEM.These results showed that Bergenia ciliata Ag2O NPs are more potent in scavengingof free radicals and can be used as prominent source of antioxidant for antioxidant25based therapies.Anticancer and cell viability test (MTT assay)Cell viability was determined using the MTT (3-[4,5-dimethylthiazol-2- yl]-2,5-diphenyltetrazolium bromide) assay.In order to evaluate the cytotoxic effect of silver oxide nanoparticles against theHuman Cervical cancer (HeLa cells) and Human colon cancer (HT-29), followingnormal cell line (FR2), the cells were seeded in T-75 flasks followed by 96-wellmicroplates (1*104 cells / well) for cell cytotoxicity assay. Next day, the cells weretreated with extract and nanoparticles and incubated at 37 °C for 24 h followed byaddition of MTT (5 mg / ml for 4 h). The plate was read at 570 nm.Anticancer activityThe prepared nanoparticles were also evaluated for cytotoxic activity on Humancolon cancer (HT-29) and Human Cervical cancer (HeLa cells). In summary, cellswere seeded at a density of 2.5 x 104 cells / mL in a 96-well plate and incubated for24 h (37 °C under 5% CO2). Next day, treatment of Ag2O NPs and Bergenia extractwas carried out at a concentration of 25-200 μg / mL for 24 hours followed by MTTassay (4-hour incubation) to assess the killing of cancer cells. The results showedthat Ag2O NPs were potent to kill cancers cells (HeLa cells and HT-29 cells lines).With an increase in the concentration of Ag2O NPs and extract, there was anincrease in cancer cell death cancer as shown in Figures 5(a) and 5(b).Figures 5(a) & 5(b) illustrate effect of silver oxide nanoparticles (Ag2O NPs)synthesized with rhizome extract of Bergenia ciliate and Bergenia ciliate extract invitro cytotoxicity against a ) Human Cervical Cancer (HeLa) cells and b) ) HumanColon Cancer (HT-29) cells respectively, wherein results were expressed as mean± SEM.The anticancer activity of the nanoparticles was dose dependent in confluentcultures. The IC50 values of Ag2O NPs were 90.6 μg / mL for HeLa cell line and 68.9μg / mL for HT-29 cell line which effectively inhibits the growth of cancer cells by53.6 % and 63.4% respectively.Cell ViabilityTo know the nontoxic range of Ag2O NPs concentrations, the inventors analyzedtheir cytotoxicity. Therefore, the cytotoxicity was evaluated by measuring thepercentage cell viability on FR2 cells MTT reduction assay after 24 hours ofincubation. The results revealed that even at the highest concentration (200 μg / ml)of the treated samples, 87 % cells remained viable. It was found that nanoparticleswere non-toxic to the cells at a dosage of 25-200 μg / ml.Figures 6 illustrate effect of silver oxide nanoparticles (Ag2O NPs) synthesized withrhizome extract of Bergenia ciliata in vitro cytotoxicity against FR2 cells.In the present invention bioactive compounds consists of alkaloids, flavonoids,tannins, phenolic compounds and saponins (Phull, A.R., Abbas, Q., Ali, A., Raza,H., Zia, M. and Haq, I.U., 2016. Antioxidant, cytotoxic and antimicrobial activitiesof green synthesized silver nanoparticles from crude extract of Bergeniaciliata. Future Journal of Pharmaceutical Sciences, 2(1), pp.31-36).The advantage that the present method of synthesis of silver oxide nanoparticlesoffers is that the method is eco-friendly as bio-compounds present in plant extractsare responsible for synthesis of nanoparticles from metal ions. Bergenia ciliataplant extracts contains bio-compounds like alkaloids, flavonoids, tannins, phenoliccompounds and saponins, etc. that are safely used for synthesis of nanoparticles atroom temperature. Taken together, the green synthesized nanoparticles are effectivein scavenging free radicals and causing cell death in cancer cells without harmingthe normal cells.Further, the process utilizes comparatively inexpensive and non-hazardouschemicals or precursor for synthesis of nanoparticles. Silver oxide nanoparticlessynthesized from the said process possess good antioxidant and anticancer anti-cancer activity.The foregoing description of the present invention will fully reveal the generalnature of the embodiment / aspect herein that others can, by applying currentknowledge, readily modify and / or adapt for various applications such specificembodiments without departing from the generic concept, and, therefore, suchadaptations and modifications should and are intended to be comprehended withinthe meaning and range of equivalents of the disclosed embodiment. It is to beunderstood that the phraseology or terminology employed herein is for the purposeof description and not of limitation.

Claims

1. Silver oxide nanoparticles useful as antioxidant and anticancer agent synthesized by using rhizome extract of Bergenia ciliata and characterized in having spherical structure with size in the range of 10 to 20 nm.

2. Silver oxide nanoparticles as claimed in claim 1 characterized in having an UV-visible absorption maximum in the range of 200 to 600 nm.

3. Silver oxide nanoparticles as claimed in claim 1, wherein the said particles showing FT-IR spectral bands having absorption peaks located 3287, 2919, 2850, 2360, 1708, 1648, 1539, 1457, 1054, 720 and 510 cm-1 associated with O-H, N-H, S-H, C≡N, C=C=C and N=C=S stretching.

4. A method for producing silver oxide nanoparticles, comprising following steps: i. preparing the rhizome extract of Bergenia ciliata; ii. drop wise adding freshly prepared rhizome extract of Bergenia ciliata to silver nitrate and mixing the solution; iii. continuously stirring the solution on a magnetic stirrer; iv. incubating the reaction mixture of step (iii) under static condition till the formation of dark brown color; v. cooling the solution; vi. re-dispersing the solution in the sterile distilled water to remove any uncoordinated biological molecules; vii. collecting the nanoparticles separated from the reaction mixture; viii. washing of nanoparticles with ethanol; and ix. collecting nanoparticles and drying in a hot air oven at 60°C for 24 hours.

5. The method as claimed in claim 4, wherein 10 mL (1:10) of freshly prepared rhizome extract of Bergenia ciliata is added to 40 ml of 1 mM silver nitrate.

6. The method as claimed in claim 4, wherein the reaction mixture is incubated at room temperature for 24-48 hours under static condition till the formation of dark brown color.

7. The method as claimed in claim 4, wherein centrifugation and re-dispersion of the solution in the sterile distilled water is repeated thrice to ensure a better separation of free entities from the silver nanoparticles.

8. The method as claimed in claim 4, wherein preparation of rhizome extract of Bergenia ciliata comprises following steps: i. collecting rhizomes of Bergenia ciliata plant; ii. washing and drying rhizomes of Bergenia ciliata plant; iii. making powder of dried rhizomes of Bergenia ciliata plant by mechanical means; iv. adding water in the ratio 1:10 w / v and boiling mixture for 30-40 minutes at 50-60°C; v. cooling the solution at room temperature; and vi. filtering the solution of preceding step to have an extract containing bioactive compounds leached from rhizomes of Bergenia ciliata plant.

9. The method as claimed in claim 8, wherein bioactive compounds consist of alkaloids, flavonoids, tannins, phenolic compounds and saponins.

10. Silver oxide nanoparticles as prepared according to the method as claimed in claim 4, wherein said nanoparticles are used as antioxidant and anticancer agent for the preparation of anticancer medicaments.